FMO5 and systemic lupus erythematosus: In vitro experiments to clarify the causal relationships among ROS levels, protein oxidation, and fibrin abnormalities provided mechanistic insights of the observed alterations.<h4>Results</h4>Patients with SLE showed increased leukocyte ROS production, mainly due to neutrophil NADPH oxidase activation.